Medication info

Welscaine Plus Cream

Prescription medicationCream
Ingredient · strength
Lidocaine›25mg / 1gPrilocaine›25mg / 1g
Manufacturer / importer
Kujoo Pharm Co., Ltd.
Appearance
White cream formulation
Packaging
500 grams/bottle, 450 grams/bottle
Approval status
Active

MFDS item code 201602583 · Notified 2016.05.10

Summary

Main use
Pain relief during procedures involving topical anesthesia of the skin, genital mucosa, and leg ulcers
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Skin: After applying this medicine, cover the area with occlusive tape. The treated area should generally remain occluded for 1-3 hours, and the effect persists for at least 1 hour after the occlusive tape is removed. 1) For needle insertion (e.g., intravenous cannulation, blood sampling), apply approximately 2g of this medicine for at least 1 hour and up to 5 hours. 2) For minor superficial surgery (e.g., excision of molluscum contagiosum), apply 1.5-2g/10㎠ for 1 hour. 3) For major superficial surgery (e.g., split-skin grafting), apply 1.5-2g/10㎠ for at least 2 hours and up to 5 hours. 2. Genital mucosa: For removal of condylomata, apply approximately 5~10g of this medicine to the treatment area for 5-10 minutes, then remove the medicine and begin the procedure immediately. 3. Leg ulcers: After applying this medicine, cover the area with occlusive tape. Use each opened tube for a single application, and discard any remaining cream after each procedure. Apply 1~2g/10cm2 for at least 30 minutes; do not use more than 10g for each treatment. For leg ulcers with tissue that is difficult to penetrate, the application time may be extended to 60 minutes, and the ulcer should be cleansed within 10 minutes after the cream is removed. When used up to 15 times over 1~2 months, there was no decrease in efficacy or increase in local reactions.
Children's dosage
○ Infants aged 3 months-12 months: Do not exceed a total amount of 2g or an application area of 16㎠.

Ingredients

Manufacturer
Kujoo Pharm Co., Ltd.

Efficacy & effects

Pain relief during procedures involving topical anesthesia of the skin, genital mucosa, and leg ulcers

  • Surface anesthesia of the skin
  • surface anesthesia of the genital mucosa
  • surface anesthesia of leg ulcer
View approved original text

This medication is used to anesthetize the surface of the skin when inserting a needle for injections or performing superficial surgical procedures. It is also used for surface anesthesia of the genital mucosa, such as before the removal of condylomas. Additionally, it is applied for surface anesthesia of leg ulcers before cleansings or superficial surgeries, such as the removal of fibrin, pus, or necrotic tissue. It is effective in various situations that require surface anesthesia of the skin or mucosa.

Dosage and Administration

Adult dosage

○ Adults 1. Skin: After applying this medicine, cover the area with occlusive tape. The treated area should generally remain occluded for 1-3 hours, and the effect persists for at least 1 hour after the occlusive tape is removed. 1) For needle insertion (e.g., intravenous cannulation, blood sampling), apply approximately 2g of this medicine for at least 1 hour and up to 5 hours. 2) For minor superficial surgery (e.g., excision of molluscum contagiosum), apply 1.5-2g/10㎠ for 1 hour. 3) For major superficial surgery (e.g., split-skin grafting), apply 1.5-2g/10㎠ for at least 2 hours and up to 5 hours. 2. Genital mucosa: For removal of condylomata, apply approximately 5~10g of this medicine to the treatment area for 5-10 minutes, then remove the medicine and begin the procedure immediately. 3. Leg ulcers: After applying this medicine, cover the area with occlusive tape. Use each opened tube for a single application, and discard any remaining cream after each procedure. Apply 1~2g/10cm2 for at least 30 minutes; do not use more than 10g for each treatment. For leg ulcers with tissue that is difficult to penetrate, the application time may be extended to 60 minutes, and the ulcer should be cleansed within 10 minutes after the cream is removed. When used up to 15 times over 1~2 months, there was no decrease in efficacy or increase in local reactions.

Children's dosage

○ Infants aged 3 months-12 months: Do not exceed a total amount of 2g or an application area of 16㎠.

Precautions

This drug is used as a local anesthetic and can cause a blood condition known as methemoglobinemia. Patients with glucose-6-phosphate dehydrogenase deficiency, congenital methemoglobinemia, cardiac or pulmonary issues, infants under 6 months old, and those exposed to oxidizing agents may be more sensitive to this condition, and caution is necessary. Symptoms of methemoglobinemia, such as the skin turning blue or unusual blood color, should be closely monitored during use. If symptoms occur, discontinue use immediately and seek appropriate treatment. Additionally, this drug should not be used by patients with hypersensitivity to it, on areas with wounds or dermatitis, in infants under 3 months, and in infants under 12 months taking certain medications. Caution should be applied in patients with anemia, the frail, elderly patients, or those with severe liver disease, as the product contains substances that can provoke skin reactions. Temporary redness, swelling, pruritus, and in rare cases, severe allergic reactions or anaphylaxis may occur. It can cause irritation if it comes into contact with the eyes; therefore, it should not be applied near the eyes, and if contact occurs, the eyes should be immediately rinsed with clean water. The risk of side effects may increase when used with other specific medications, so patients should consult with their healthcare provider about any medications they are currently taking. During pregnancy, it should only be used if the benefits outweigh the risks, as determined by a physician, and caution is also necessary for nursing mothers. It should be used restrictively in children, especially infants under 3 months of age, and it is safer not to use it on the genital mucosa. In cases of overdose, methemoglobinemia and central nervous system and cardiovascular symptoms may appear, requiring immediate medical intervention, and patients showing symptoms should be closely monitored for several hours. The amount absorbed by the body can vary depending on the skin condition, application area, and duration of application, so caution is warranted during use. High doses and prolonged use should be avoided considering the potential for carcinogenicity.

Side effects

Pallor, erythema, edema, initial burning sensation, itching, purpura, petechial hemorrhage, methemoglobinemia, allergic reaction, anaphylactic shock, corneal irritation, paresthesia, skin irritation, central nervous system excitation symptoms, central nervous system depression, myocardial depression, convulsions, arrhythmia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1°C and 30°C. This will help safely preserve the medication's effectiveness.

Appearance and packaging

Appearance

White cream formulation

Package unit

500 grams/bottle, 450 grams/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.